Bumrungrad Hospital Public Company Limited AI Price Prediction

With EPS of €0.23 and a PE ratio of 21.33, Bumrungrad Hospital Public Company Limited is priced at a moderate premium relative to typical hospital/healthcare providers, implying the market expects steady but not explosive earnings growth. In the absence of detailed revenue and margin data, the valuation suggests a solid, profitable franchise rather than a deep-value or high-growth outlier. Overall, the earnings profile looks stable but not clearly mispriced in either direction.

• EPS of €0.23 combined with a share price of €4.92 implies a PE of 21.33, consistent with a quality, profitable operator in a defensive sector rather than a distressed or hyper-growth name.
• A PE in the low‑20s suggests investors are willing to pay a premium for earnings stability and brand strength, but it also limits upside if earnings growth does not accelerate.
• Lack of visible deterioration in earnings (no negative EPS or extreme multiple) points to a fundamentally sound business, but without additional revenue/margin trends it is difficult to argue for a strongly bullish or bearish stance purely on fundamentals.

The stock trades at €4.92, modestly above its 200‑day moving average of €4.54, indicating a mild longer‑term uptrend. A 0.8% decline over the last month suggests short‑term consolidation rather than a sharp sell‑off or breakout. Without explicit RSI data, price action versus the 200‑day average points to a technically constructive but not strongly momentum‑driven setup.

• Current price (€4.92) is about 8% above the 200‑day moving average (€4.54), a classic sign of a positive longer‑term trend that has not become excessively extended.
• The stock is down only 0.8% over the past month, implying limited short‑term weakness and more of a sideways or mildly corrective phase within the broader trend.
• Given the modest premium to the 200‑day average and no evidence of extreme overextension, the technical picture is balanced: neither clearly overbought nor oversold, consistent with a neutral to slightly constructive bias.

Estimated monthly web traffic of about 653,751 visitors indicates a strong digital footprint for a hospital operator, but no growth trend is specified, limiting directional insight. Social media data show a mixed pattern: small declines in Twitter/X and Facebook followers but modest growth on Instagram, TikTok, and YouTube, suggesting stable overall brand engagement with a gradual shift toward younger and video‑centric platforms. Overall, alternative data point to a steady, well‑known brand rather than a rapidly accelerating or deteriorating demand environment.

• Web traffic at roughly 653k visitors per month is substantial and consistent with a well‑established healthcare brand, but without time‑series data it is hard to infer acceleration or deceleration in patient interest.
• Social media signals are mixed: slight follower declines on Twitter/X (‑0.1% in 90 days) and Facebook (‑0.2%) contrast with incremental growth on Instagram (+0.3%), TikTok (+0.5%), and YouTube (+0.4%), indicating stable overall reach with a tilt toward growth on newer platforms.
• The breadth of the company’s online audience (millions on Facebook, hundreds of thousands on YouTube and Twitter/X) supports brand strength and marketing reach, but the modest magnitude of recent changes does not strongly signal a near‑term inflection in business performance.

Taken together, Bumrungrad Hospital Public Company Limited’s valuation, technical profile, and alternative data suggest a stable, quality healthcare name trading at a reasonable premium, but without clear catalysts for sharp upside or downside in the near term. The stock sits modestly above its 200‑day moving average, alternative data show steady but not explosive engagement, and the PE multiple implies expectations for continued solid earnings rather than dramatic growth. Overall, the setup appears balanced, warranting a neutral stance pending new information on earnings growth or demand trends.

• Fundamentals and valuation (PE ~21) indicate a solid, profitable operator with earnings stability largely reflected in the current price.
• Technical and alternative data are constructive but not strongly directional, pointing to a steady brand and modest uptrend rather than a high‑conviction bullish or bearish scenario.